- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1382
0 new
Companies which are more than 50% undervalued based on analyst price target.
1,382 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CYN | US$6.83 | 1.0% | -99.8% | US$979.2k | US$1,799.99 | PS9.6x | S214.0% | n/a | Software | ||
AEON | US$0.75 | -84.6% | -99.9% | US$833.0k | US$360.00 | PE0.06x | n/a | n/a | Pharmaceuticals & Biotech | ||
SCPX | US$0.17 | -11.6% | -99.7% | US$832.5k | US$5.00 | PS0.08x | E75.2% | n/a | Pharmaceuticals & Biotech | ||
NMHI | US$0.30 | -14.9% | -99.8% | US$812.0k | US$21.00 | PS0.08x | E65.5% | n/a | Capital Goods | ||
SONX | US$1.89 | -19.6% | -94.8% | US$805.6k | US$30.00 | PS0.02x | E21.8% | n/a | Healthcare | ||
TCBP | US$1.95 | -20.4% | -99.0% | US$800.3k | US$48.00 | PB0.3x | E-10.1% | n/a | Pharmaceuticals & Biotech | ||
BPTH | US$0.18 | 5.1% | -97.1% | US$774.4k | US$12.00 | PE-0.07x | E58.3% | n/a | Pharmaceuticals & Biotech | ||
LFLY | US$0.22 | -4.1% | -91.2% | US$659.9k | US$7.59 | PS0.02x | S-2.4% | n/a | Media | ||
BIOR.Q | US$0.14 | -17.6% | -98.9% | US$619.2k | US$34.00 | PS0.7x | E-21.5% | n/a | Pharmaceuticals & Biotech | ||
CYTO.F | US$0.10 | -25.2% | -95.7% | US$470.9k | US$5.29 | PB0.07x | E-4.4% | n/a | Pharmaceuticals & Biotech | ||
SHWZ | US$0.0055 | -72.5% | -99.6% | US$440.9k | US$2.70 | PS0.003x | S6.4% | n/a | Pharmaceuticals & Biotech | ||
ZPTA | US$0.01 | 0% | -99.9% | US$386.3k | US$1.75 | PS0.06x | E48.8% | n/a | Software | ||
LGMK | US$0.18 | -29.4% | -99.3% | US$372.6k | US$4.00 | PS0.04x | n/a | n/a | Healthcare | ||
GMVD.F | US$0.0002 | 100.0% | -98.5% | US$52.9k | US$210.00 | n/a | n/a | n/a | Healthcare |